Literature DB >> 12544735

Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy.

Hidenobu Takahashi1, Ichiro Fuse, Takashi Abe, Noriko Yoshino, Yoshifusa Aizawa.   

Abstract

A 59-year-old man diagnosed as having Hashimoto's thyroditis, primary biliary cirrhosis (PBC) and membranous nephropathy (MN) showed consciousness disturbance, convulsions of the upper part of his body, and rapid progression of anemia, which seemed to be derived from subdural and retroperitoneal hemorrhage, respectively. He had been diagnosed as having eosinophilia about 6 weeks before the attack. Coagulation tests revealed a prolonged activated partial thromboplastin time and prothrombin time, which could not be normalized by mixing with normal plasma. Factor V (FV) activity was severely decreased and the purified immunoglobulin G of the patient inhibited normal plasma FV activity in a dose-dependent manner, suggesting the presence of antibody-mediated circulating inhibitors specific for FV. Treatment with steroids and azathioprine as well as plasmapheresis led to improvement of his clinical symptoms, normalization of the coagulation tests, and disappearance of eosinophilia. However, the inhibitor reappeared about 7 months later in association with eosinophilia, which was also improved by steroid therapy. To our knowledge, this is the first report of the co-existence of these three kinds of immune-mediated disorders, and the first report concerning the association between acquired FV inhibitors and PBC with MN. A new unknown immune mechanism, which causes eosinophilia, may be involved in the development of the FV inhibitor in this patient. Copyright 2003 Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544735     DOI: 10.1097/00001721-200301000-00016

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  6 in total

Review 1.  Acquired factor V inhibitors: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

2.  Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis.

Authors:  Shuzo Sato; Rie Saito; Haruyo Iwadate; Tomoyuki Asano; Kazumichi Abe; Atsushi Takahashi; Hiroko Kobayashi; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Clin J Gastroenterol       Date:  2012-07-20

3.  Acquired Factor V Inhibitors in a Patient with End-stage Renal Disease.

Authors:  Atsushi Kitazawa; Hideo Misawa; Katsuhiro Nagahori; Ryo Koda; Atsunori Yoshino; Shinya Kawamoto; Tetsuro Takeda
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

4.  Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease.

Authors:  Eisuke Katsuren; Kentaro Kohagura; Takanori Kinjyo; Ryo Zamami; Takuto Nakamura; Nanako Oshiro; Yoshitsugu Sunagawa; Kumiko Omine; Yuki Kudo; Yuki Shinzato; Tsukasa Osaki; Masayoshi Souri; Akitada Ichinose; Masanobu Yamazato; Akio Ishida; Yusuke Ohya
Journal:  CEN Case Rep       Date:  2022-08-09

5.  Anti-Factor V inhibitor in patients with autoimmune diseases: case report and literature review.

Authors:  Shinsaku Imashuku; Takeshi Hasegawa; Kagekatsu Kubo; Masaki Nakato; Midori Shima
Journal:  Int Med Case Rep J       Date:  2011-04-20

6.  Membranous nephropathy with acquired factor V inhibitor: a case report.

Authors:  Shinji Kitamura; Mahito Misawa; Sayaka Namba; Kenji Tsuji; Rikako Torigoe; Midori Shima; Hirofumi Makino
Journal:  BMC Res Notes       Date:  2013-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.